Overexpression of serum sST2 is associated with poor prognosis in acute-on-chronic hepatitis B liver failure

Clinics and Research in Hepatology and Gastroenterology

Volumn 39, Issue 3, 2015, Pages 315-323

  Gao, Shuai ^a   Huan, Shu Ling ^a   Han, Li Yan ^a,b   Li, Feng ^a   Ji, Xiang Fen ^a   Li, Xin You ^a   Fan, Yu Chen ^a,b   Wang, Kai ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR LIKE 1; INTERLEUKIN 33; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; END STAGE LIVER DISEASE; FEMALE; GENE OVEREXPRESSION; HUMAN; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; SEX DIFFERENCE; SURVIVAL TIME; ACUTE-ON-CHRONIC LIVER FAILURE; BIOSYNTHESIS; BLOOD; CHRONIC HEPATITIS B; COMPLICATION; MIDDLE AGED; YOUNG ADULT;

ACUTE-ON-CHRONIC LIVER FAILURE; ADULT; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-33; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECEPTORS, CELL SURFACE; YOUNG ADULT;

EID: 84930872585     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2014.10.012     Document Type: Article

References (33)

1. Lok A.S., McMahon B.J. Chronic hepatitisB. Hepatology 2007, 45(2):507-539.
2. Bosch F.X., Ribes J., Cleries R., Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005, 9(2):191-211. [v].
3. Sarin S.K., Kumar A., Almeida J.A., Chawla Y.K., Fan S.T., Garg H., et al. Acute-on-chronic liver failure: consensus recommendations of the Asian-Pacific Association for the Study of the Liver (APASL). Hepatol Int 2009, 3(1):269-282.
4. Zheng M.H., Shi K.Q., Lin X.F., Xiao D.D., Chen L.L., Liu W.Y., et al. A model to predict 3-month mortality risk of acute-on-chronic hepatitis B liver failure using artificial neural network. J Viral Hepat 2013, 20(4):248-255.
5. Polson J., Lee W.M. AASLD position paper: the management of acute liver failure. Hepatology 2005, 41(5):1179-1197.
6. Wang L.Y., Meng Q.H., Zou Z.Q., Fan Y.C., Han J., Qi Z.X., et al. Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure. Dig Dis Sci 2012, 57(3):667-674.
7. Roth G.A., Zimmermann M., Lubsczyk B.A., Pilz J., Faybik P., Hetz H., et al. Up-regulation of interleukin 33 and soluble ST2 serum levels in liver failure. J Surg Res 2010, 163(2):e79-e83.
8. Guo L.M., Liu J.Y., Xu D.Z., Li B.S., Han H., Wang L.H., et al. Application of Molecular Adsorbents Recirculating System to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome. Liver Int 2003, 23(Suppl. 3):16-20.
9. Baekkevold E.S., Roussigne M., Yamanaka T., Johansen F.E., Jahnsen F.L., Amalric F., et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 2003, 163(1):69-79.
10. Onda H., Kasuya H., Takakura K., Hori T., Imaizumi T., Takeuchi T., et al. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab 1999, 19(11):1279-1288.
11. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23(5):479-490.
12. Alves-Filho J.C., Sonego F., Souto F.O., Freitas A., Verri W.A., Auxiliadora-Martins M., et al. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 2010, 16(6):708-712.
13. Arshad M.I., Rauch M., L'Helgoualc'h A., Julia V., Leite-de-Moraes M.C., Lucas-Clerc C., et al. NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis. Eur J Immunol 2011, 41(8):2341-2348.
14. Wang J., Zhao P., Guo H., Sun X., Jiang Z., Xu L., et al. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C. Mediators Inflamm 2012, 2012:819636.
15. Marvie P., Lisbonne M., L'Helgoualc'h A., Rauch M., Turlin B., Preisser L., et al. Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J Cell Mol Med 2010, 14(6B):1726-1739.
16. Lok A.S., McMahon B.J. Chronic hepatitisB: update 2009. Hepatology 2009, 50(3):661-662.
17. Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Therneau T.M., Kosberg C.L., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001, 33(2):464-470.
18. Shen Q., Fan J., Yang X.R., Tan Y., Zhao W., Xu Y., et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol 2012, 13(8):817-826.
19. Gao S., Fan Y.C., Zhao J., Sun F.K., Han J., Zhao Z.H., et al. A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase ≤2 upper limit of normal. Liver Int 2014, 34(7):e229-e237.
20. Hui A.Y., Chan H.L., Wong V.W., Liew C.T., Chim A.M., Chan F.K., et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005, 100(3):616-623.
21. Malinchoc M., Kamath P.S., Gordon F.D., Peine C.J., Rank J., ter Borg P.C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000, 31(4):864-871.
22. Stewart C.A., Malinchoc M., Kim W.R., Kamath P.S. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007, 13(10):1366-1371.
23. Zheng M.H., Shi K.Q., Fan Y.C., Li H., Ye C., Chen Q.Q., et al. A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure. Clin Gastroenterol Hepatol 2011, 9(4):351-6000.
24. Rolando N., Wade J., Davalos M., Wendon J., Philpott-Howard J., Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000, 32(4 Pt 1):734-739.
25. Bergers G., Reikerstorfer A., Braselmann S., Graninger P., Busslinger M. Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J 1994, 13(5):1176-1188.
26. Oshikawa K., Yanagisawa K., Tominaga S., Sugiyama Y. Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy 2002, 32(10):1520-1526.
27. Yang Z., Liang Y., Xi W., Li C., Zhong R. Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population. Clin Exp Med 2011, 11(2):75-80.
28. Wang J., Cai Y., Ji H., Feng J., Ayana D.A., Niu J., et al. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B. J Interferon Cytokine Res 2012, 32(6):248-253.
29. Zhang J.Y., Zhang Z., Lin F., Zou Z.S., Xu R.N., Jin L., et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010, 51(1):81-91.
30. Zou Z., Li B., Xu D., Zhang Z., Zhao J.M., Zhou G., et al. Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection. J Clin Gastroenterol 2009, 43(2):182-190.
31. Pan C., Gu Y., Zhang W., Zheng Y., Peng L., Deng H., et al. Dynamic changes of lipopolysaccharide levels in different phases of acute-on-chronic hepatitis B liver failure. PLoS One 2012, 7(11):e49460.
32. Wang L.Y., Fan Y.C., Zhao J., Gao S., Sun F.K., Han J., et al. Elevated expression of tumour necrosis factor-alpha-induced protein 8 (TNFAIP8)-like 2 mRNA in peripheral blood mononuclear cells is associated with disease progression of acute-on-chronic hepatitis B liver failure. J Viral Hepat 2014, 21(1):64-73.
33. Liang X.S., Li C.Z., Zhou Y., Yin W., Liu Y.Y., Fan W.H. Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure. World J Gastroenterol 2014, 20(26):8558-8571.